CASE STUDY
Limited resection procedure for metachronous lung neoplasm
 
More details
Hide details
1
2nd Department of Propedeutic Surgery, National and Kapodistrian University of Athens Medical School, “Laiko” General Hospital, Athens, Greece
 
2
Respiratory Intensive Care Unit, ‘Sotiria’ Hospital of Chest Diseases, Athens, Greece
 
 
Corresponding author
Periklis Tomos   

Thoracic Surgery Second Department of Propedeutic Surgery, University of Athens Medical School, “Laiko” General Hospital 17 Agiou Thoma St., 11527, Athens, Greece
 
 
Pneumon 2012;25(4):428-431
 
KEYWORDS
ABSTRACT
A 57 year-old male smoker presented with weight loss and hypertrophic osteoarthropathy. Imaging studies revealed a solid mass (maximum diameter 4.2 cm) located in the left lung and left upper lobectomy was carried out. Histopathology showed low differentiated adenocarcinoma and the patient received adjuvant chemotherapy. Bronchoscopy performed 3 years later to exclude specific infection revealed complete obstruction of the posterior segment of the right upper lobe by a highly vascular, smooth margined mass. At thoracotomy the frozen section was negative for malignancy and histopathological examination revealed a typical carcinoid tumour. The excellent prognosis of this histological type of tumour allowed avoidance of a major surgical procedure and the lesion was resected by bronchotomy with reconstruction of the bronchial gap. 
 
REFERENCES (24)
1.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934–59.
 
2.
D’Addario G, Felip E, Group EGW. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20:68–70.
 
3.
Ettinger DS, Akerley W, Bepler G, et al. Non-small cell lung cancer. J Natl Compr Canc Netw 2010;8:740–801.
 
4.
Colice GL, Rubins J, Unger M, Physicians AC of C. Follow-up and surveillance of the lung cancer patient following curativeintent therapy. Chest 2003;123:-283.
 
5.
Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg 1995;59:863–6.
 
6.
Jeremic B, Shibamoto Y, Acimovic L, et al. Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 2001;19:1056–63.
 
7.
Shen KR, Meyers BF, Larner JM, Jones DR, Physicians AC of C. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:-305.
 
8.
Todd TR, Cooper JD, Weissberg D, Delarue NC, Pearson FG. Bronchial carcinoid tumors: twenty years’ experience. J Thorac Cardiovasc Surg 1980;79:532–6.
 
9.
Kurul IC, Top\ccu S, Taştepe I, Yazici U, Altinok T, Cetin G. Surgery in bronchial carcinoids: experience with 83 patients. Eur J Cardiothorac Surg 2002;21:883–7.
 
10.
Rea F, Rizzardi G, Zuin A, et al. Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients. Eur J Cardiothorac Surg 2007;31:186–91.
 
11.
Machuca TN, Cardoso PF, Camargo SM, et al. Surgical treatment of bronchial carcinoid tumors: a single-center experience. Lung Cancer 2010;70:158–62.
 
12.
Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg 1990;99:769–77.
 
13.
Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Operative approach for multiple primary lung carcinomas. J Thorac Cardiovasc Surg 1998;115:836–40.
 
14.
Verhagen AF, Tavilla G, van de Wal HJ, Cox AL, Lacquet LK. Multiple primary lung cancers. Thorac Cardiovasc Surg 1994;42:40–4.
 
15.
Rosengart TK, Martini N, Ghosn P, Burt M. Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg 1991;52:773–8.
 
16.
Rea F, Rizzardi G, Marulli G, Bortolotti L. Metachronous bronchial carcinoid tumor. Eur J Cardiothorac Surg 2006;30:394–6.
 
17.
Manoutcheri MA, Bosse U, Füzesi L, Klinke F. Multicentric metachronous central carcinoid of the lung: a case report. Thorac Cardiovasc Surg 1999;47:337–9.
 
18.
Flynn MJ, Rassl D, El Shahira A, Higgins B, Barnard S. Metachronous and synchronous lung tumors: five malignant lung pathologies in 1 patient during 7 years. Ann Thorac Surg 2004;78:2154–5.
 
19.
Rosado de Christenson ML, Abbott GF, Kirejczyk WM, Galvin JR, Travis WD. Thoracic carcinoids: radiologic-pathologic correlation. Radiographics 1999;19:707–36.
 
20.
García-Yuste M, Matilla JM, Cueto A, et al. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur J Cardiothorac Surg 2007;31:192–7.
 
21.
Brunelli A, Charloux A, Bolliger CT, et al. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. Eur J Cardiothorac Surg 2009;36:181–4.
 
22.
Donington JS, Miller DL, Rowland CC, et al. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg 2002;74:154–8.
 
23.
Fuks L, Fruchter O, Amital A, Fox BD, Abdel Rahman N, Kramer MR. Long-term follow-up of flexible bronchoscopic treatment for bronchial carcinoids with curative intent. Diagn Ther Endosc 2009;2009:782961–782961.
 
24.
Katsenos S, Rojas-Solano J, Schuhmann M, Becker HD. Bronchoscopic long-term palliation of a recurrent atypical carcinoid tumor. Respiration 2011;81:345–50.
 
eISSN:1791-4914
ISSN:1105-848X
Journals System - logo
Scroll to top